AKRN is pleased to announce the partnership agreement with the European Pharmaceutical Law Group – Eupharlaw.

Health Law embraces the regulatory and legal contents that affect research, development, manufacture, authorization, financing, marketing, prescription, dispensing, and any other aspect of the life cycle of the medicine or medical device.

Eupharlaw specializes in consulting and legal advice on European Law related to a vast range of products for the health sector (medicines, medical devices, biocides, food supplements…) and the activity of the industries involved in.

The Clinical Research Sector is a highly regulated area of high innovation; therefore, it requires a demanding legal-technical specialization.

Our two companies share a passion for providing optimized services tailored to our clients and MedTech partners.

Fuente: AKRN Scientific Consulting

https://akrnconsulting.com/akrn-eupharlaw-partnership/
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

A dietary supplement has beneficial effe...

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

Research led by IIBB-CSIC and CIBEREHD scientists identifies S-adenosy...

Photos Stream